Faqihi, Fahad
Nasim, Nasir
Noor, Alfateh
Akhtar, Saima
Balshi, Ahmed
Balhamar, Abdullah
Alqahtani, Saleh A.
Memish, Ziad A.
Karakitsos, Dimitrios
2020-10-22T20:09:14Z
2020-10-22T20:09:14Z
2020
2213-0071
https://doi.org/10.1016/j.rmcr.2020.101252
http://hdl.handle.net/20.500.12010/14792
This is a rare case-report of a young female with systemic lupus erythematosus and end-stage
kidney disease (on maintenance hemodialysis) who was admitted to our intensive care unit due
to life-threatening COVID-19. The patient was diagnosed with a flare of lupus; while being on
maintenance hydroxychloroquine therapy. However, after the administration of steroids she
made an uneventful recovery and was discharged home. In this report, the diagnostic dilemmas
and the therapeutic challenges due to the overlapping clinical, imaging, and laboratory findings
between lupus and COVID-19 pneumonitis are outlined. In conclusion, patients with lupus may
be affected by COVID-19 despite the administration of hydroxychloroquine. The administration
of steroids may have a beneficial effect on mitigating both the flare of SLE and the COVID-19
associated hyperinflammation.
19 páginas
application/pdf
eng
Respiratory Medicine Case Reports
reponame:Expeditio Repositorio Institucional UJTL
instname:Universidad de Bogotá Jorge Tadeo Lozano
COVID-19
Systemic Lupus Erythematosus
Acute Respiratory Failure
End-Stage Kidney Disease
Steroid Therapy
Hydroxychloroquine
COVID-19 in a patient with a flare of systemic lupus erythematosus: a rare case- report
Artículo
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/acceptedVersion
Abierto (Texto Completo)
https://doi.org/10.1016/j.rmcr.2020.101252
http://purl.org/coar/resource_type/c_2df8fbb1